Former gsk PA head lands Oxfam International EU job

A former GlaxoSmithKline (gsk) senior political lobbyist is to join

Oxfam, the charity which has fiercely criticised the pharmaceutical

industry over the high price of Aids drugs.

David Earnshaw quit gsk in February, soon after it was created from the

merger of Glaxo Wellcome - one of the world's leading producers of Aids

treatment products - and SmithKline Beecham (SB).

He had previously been SB head of European government affairs.

He takes up the newly-created role of EU representative for Oxfam

International next month and is already urging his former employers to

speed up a reduction in drugs prices.

He said: 'The pharmaceutical industry in general - and that includes

gsk - needs to be doing more.

'The pharmaceutical companies need to act. If they don't, governments

will do it for them.'

However, he denies that his latest role is a 'poacher turned gamekeeper'

move.'I'm not interested in sides or conflict. I want to see the NGOs,

governments and the companies working together to help solve this

problem,' he said.

Earnshaw, who will be based in Brussels and is likely to head a

three-strong team, reports to Oxfam advocacy director Phil Twyford, who

is based in Washington.

Josephine Wood, previously SB EU policy adviser, has taken over from

Earnshaw to head lobbying work at gsk's Brussels office.

Earnshaw is one of a raft of former SB senior staff to have left the

merged company.

Last month, gsk announced that James Hill, SB corporate affairs chief,

will leave within the next three months.

Lynne Smith, former SB director and V-P of corporate communications

(Europe and international) left last month.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in